|
|
Volumn 105, Issue 17, 2002, Pages 2012-2018
|
|
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
a
|
|
Author keywords
Angina; Angiogenesis; Gene therapy; Growth substances; Ischemia
|
|
Indexed keywords
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
PLASMID DNA;
VASCULOTROPIN;
ADULT;
ANGINA PECTORIS;
ARTICLE;
CATHETER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
EXERCISE;
FEMALE;
FUNCTIONAL ASSESSMENT;
GENE TRANSFER;
HEART CATHETERIZATION;
HEART MUSCLE ISCHEMIA;
HUMAN;
MALE;
NONVIRAL GENE DELIVERY SYSTEM;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
ANGINA PECTORIS;
BODY SURFACE POTENTIAL MAPPING;
CATHETERIZATION;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
ENDOTHELIAL GROWTH FACTORS;
EXERCISE TEST;
FEMALE;
GENE THERAPY;
HEART VENTRICLES;
HUMANS;
LYMPHOKINES;
MALE;
MIDDLE AGED;
MYOCARDIAL ISCHEMIA;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0037197740
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000015982.70785.B7 Document Type: Article |
|
Times cited : (449)
|
|
References (29)
|
